查看购物车
  • Traditional Chinese
  • English
  • Japanese
欧洲生物资讯市场：按产品和服务、产业、应用和国家分類的分析和预测（2025-2035 年）
市场调查报告书
商品编码
1915216

欧洲生物资讯市场：按产品和服务、产业、应用和国家分類的分析和预测（2025-2035 年）

Europe Bioinformatics Market: Focus on Product and Services, Sector, Application, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 68 Pages | 商品交期: 1-5个工作天内

价格

欧洲生物资讯市场规模预计将从 2024 年的 42.7 亿美元成长到 2035 年的 154.2 亿美元，在预测期（2025-2035 年）内复合年增长率为 12.42%。

生物资讯学是一门交叉学科，它结合了电脑科学、生物学、化学、数学和统计学，用于评估复杂的生物数据。它对于理解生物分子和系统的组成、功能和发育至关重要，并支持蛋白质相互作用的研究、疾病相关基因的鑑定以及基因表现分析。此外，它在代谢通路研究、精准医疗和药物研发中也发挥关键作用。次世代定序技术正在加速基因组数据的成长，从而增加了医疗保健和研究领域对生物资讯工具的需求。人工智慧和机器学习的发展进一步提升了数据分析能力，巩固了生物资讯学在欧洲医疗保健、遗传学和生命科学研究领域的关键地位。

关键市场统计数据
预测期 2025-2035
2025 年评估 47.8亿美元
2035 年预测 154.2亿美元
复合年增长率 12.42%

市场概览

受系统生物学、蛋白质组学和基因组学领域对高级数据分析需求的日益增长的推动，欧洲生物资讯市场正经历显着增长。生物资讯整合了生物学、化学、数学、统计学和电脑技术，用于管理和解读复杂的生物数据集，使研究人员和医学专业人员能够了解分子结构、基因活性和蛋白质相互作用。其应用领域包括个人化医疗、药物研发、疾病相关基因的鑑定以及代谢和讯号网络的分析。

次世代定序(NGS)、高通量筛检和分子诊断技术的进步推动了基因组数据的快速成长，进而促进了市场发展。精准医疗计画在欧洲各国的日益普及，使得标靶治疗成为可能，并改善了患者的治疗效果，从而推动了对生物资讯解决方案的需求。研究机构、製药公司和生技公司正积极投资生物资讯平台，以提高效率、加速药物研发并实现数据驱动的决策。

云端运算、人工智慧和机器学习等技术进步正使生物资讯分析更快、更准确、更具可扩展性。政府旨在促进基因组学研究、支持生命科学创新以及加强欧洲合作的计画也为市场提供了支持。儘管面临资料安全和合格专业人员短缺等挑战，生物资讯学仍然是欧洲医疗保健、基因组学和生命科学研究领域的重要组成部分，并具有进一步技术发展和进步的空间。

市场区隔:

细分方式 1：依产品/服务

  • 生物资讯软体和工具
  • 生物资讯服务

细分2：按行业

  • 医学生物技术
  • 动物生物技术
  • 植物生物技术
  • 法医学生物技术
  • 其他的

细分 3：按应用

  • 基因组学
  • 蛋白质体学
  • 转录组学
  • 代谢体学
  • 其他的

细分 4：按地区

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的

本报告考察了欧洲生物资讯市场，并总结了关键趋势、市场影响因素分析、法律制度、市场规模趋势和预测、按各个细分市场、地区/主要国家进行的详细分析、竞争格局以及主要企业的概况。

目录

执行摘要

范围和定义

第一章 欧洲生物资讯学市场：产业展望

  • 市场趋势：当前及未来影响评估
    • 人工智慧和机器学习在生物资讯解决方案中的策略整合
    • 将多体学数据整合到生物资讯市场
    • 量子计算变革生物资讯学
  • 监管状态
  • 定价分析
  • 市场动态
    • 市场驱动因素
    • 市场挑战
    • 市场机会

第二章 各地区生物资讯市场

  • 欧洲
    • 区域概览
    • 市场成长驱动因素
    • 市场问题
    • 分析师观点
    • 市场规模及预测

第三章 竞争标竿分析与公司概况

  • 公司简介
    • Eurofins Scientific
    • Fios Genomics
    • QIAGEN
    • SOPHiA GENETICS

第四章调查方法

Product Code: BHD3547SS

This report can be delivered in 2 working days.

Introduction to Europe Bioinformatics Market

The Europe bioinformatics market is projected to reach $15.42 billion by 2035 from $4.27 billion in 2024, growing at a CAGR of 12.42% during the forecast period 2025-2035. In Europe, bioinformatics is an interdisciplinary field that combines computer science, biology, chemistry, mathematics, and statistics to evaluate complicated biological data. It is essential for comprehending the composition, operation, and development of biomolecules and systems, supporting research on protein interactions, disease gene identification, and gene expression analysis. Additionally, the field is essential for metabolic pathway research, precision medicine, and drug development. Next-generation sequencing technologies have accelerated the growth of genomic data, which has raised demand for bioinformatics tools in the healthcare and research sectors. AI and machine learning developments are improving data analysis even further, solidifying bioinformatics as a key component of European healthcare, genetics, and life sciences research.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$4.78 Billion
2035 Forecast$15.42 Billion
CAGR12.42%

Market Introduction

The market for bioinformatics in Europe is expanding significantly due to the growing need for sophisticated data analysis in systems biology, proteomics, and genomics. Researchers and medical professionals can comprehend molecular structures, gene activities, and protein interactions by using bioinformatics, which combines biology, chemistry, mathematics, statistics, and computer technology to manage and interpret complex biological datasets. Personalized medicine, drug discovery, illness gene identification, and the investigation of metabolic and signaling networks are some of its uses.

The market growth is propelled by the rapid expansion of genomic data, supported by developments in next-generation sequencing (NGS) technologies, high-throughput screening, and molecular diagnostics. The demand for bioinformatics solutions has increased due to the growing adoption of precision medicine programs throughout European nations, which allow for focused therapies and better patient outcomes. In order to improve productivity, shorten the time it takes to discover new drugs, and enable data-driven decision-making, research institutes, pharmaceutical corporations, and biotechnology companies are actively investing in bioinformatics platforms.

Bioinformatics analyses are becoming faster, more accurate, and more scalable thanks to technological advancements like cloud computing, artificial intelligence, and machine learning. The market is also being supported by government programs that encourage genomics research, innovation in the life sciences, and cooperative ventures around Europe. Bioinformatics is still a vital part of Europe's healthcare, genomics, and life sciences research environment, with room to develop and advance technologically despite obstacles such data security issues and the need for qualified experts.

Market Segmentation:

Segmentation 1: By Product and Services

  • Bioinformatics Software and Tools
  • Bioinformatics Services

Segmentation 2: By Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Forensic Biotechnology
  • Others

Segmentation 3: By Application

  • Genomics
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Others

Segmentation 4: By Region

  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe

Europe Bioinformatics Market Trends, Drivers and Challenges

Market Trends

  • Increasing integration of AI and machine learning for faster, more accurate data analysis
  • Growing use of cloud-based bioinformatics platforms for scalable data storage and collaboration
  • Rising adoption of next-generation sequencing (NGS) and high-throughput technologies in genomics and proteomics research
  • Expansion of precision medicine and personalized therapy programs across hospitals and research centers
  • Enhanced application of bioinformatics in drug discovery, molecular diagnostics, and biomarker identification
  • Growing collaborations between pharmaceutical companies, academic institutions, and technology providers to advance bioinformatics research

Market Drivers

  • Rapid increase in genomic, proteomic, and metabolomic data requiring sophisticated analysis tools
  • Rising demand for personalized medicine and targeted therapeutics in Europe
  • Strong government and EU initiatives promoting life sciences research and genomics projects
  • Expansion of biotechnology and pharmaceutical R&D activities in key European countries
  • Technological advancements in AI, machine learning, and data analytics improving bioinformatics capabilities
  • Need to reduce drug development timelines and enhance research efficiency

Market Challenges

  • Shortage of skilled bioinformatics professionals to manage and interpret complex datasets
  • High costs associated with advanced bioinformatics platforms and software
  • Data privacy and security concerns, particularly with patient genomic information
  • Integration challenges across diverse datasets and legacy systems
  • Regulatory compliance complexities for clinical and healthcare bioinformatics applications

How can this report add value to an organization?

Product/Innovation Strategy: The Europe bioinformatics market has been extensively segmented based on various categories, such as product and services, sector, application, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe bioinformatics market has numerous established players with product portfolios. Key players in the Europe bioinformatics market, analyzed and profiled in the study, include established players offering products and services for bioinformatics.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Eurofins Scientific
  • Fios Genomics Ltd.
  • QIAGEN
  • SOPHiA GENETICS

Table of Contents

Executive Summary

Scope and Definition

1 Europe Bioinformatics Market: Industry Outlook

  • 1.1 Market Trends: Current and Future Impact Assessment
    • 1.1.1 Strategic Integration of AI and ML in Bioinformatics Solutions
    • 1.1.2 Integration of Multi-Omics Data in the Bioinformatics Market
    • 1.1.3 Quantum Computing to Transform Bioinformatics
  • 1.2 Regulatory Landscape
  • 1.3 Pricing Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Market Drivers
      • 1.4.1.1 Rising Private and Public Investments in the Bioinformatics Industry
      • 1.4.1.2 Growing Demand for Bioinformatics in Drug Discovery
      • 1.4.1.3 Expanding Genomic Data Propelling the Demand for Bioinformatics Tools
    • 1.4.2 Market Challenges
      • 1.4.2.1 Data Complexity and Heterogeneity Limiting Bioinformatics Growth
      • 1.4.2.2 Ethical and Data Privacy Challenges Impacting Bioinformatics Adoption
    • 1.4.3 Market Opportunities
      • 1.4.3.1 Rising Importance of Metagenomics Offering Growth Potential for Bioinformatics

2 Bioinformatics Market, by Region, $Billion, 2023-2035

  • 2.1 Europe
    • 2.1.1 Regional Overview
    • 2.1.2 Driving Factors for Market Growth
    • 2.1.3 Factors Challenging the Market
    • 2.1.4 Analyst View
    • 2.1.5 Market Sizing and Forecast
      • 2.1.5.1 Europe Bioinformatics Market (by Product and Services)
      • 2.1.5.2 Europe Bioinformatics Market (by Application)
      • 2.1.5.3 Europe Bioinformatics Market (by Sector)
      • 2.1.5.4 Europe Bioinformatics Market (by Country)
        • 2.1.5.4.1 U.K.
          • 2.1.5.4.1.1 Country Overview
          • 2.1.5.4.1.2 Driving Factors Market Growth
          • 2.1.5.4.1.3 Factors Challenging the Market
          • 2.1.5.4.1.4 Analyst View
          • 2.1.5.4.1.5 Market Sizing and Forecast
        • 2.1.5.4.2 Germany
          • 2.1.5.4.2.1 Country Overview
          • 2.1.5.4.2.2 Driving Factors Market Growth
          • 2.1.5.4.2.3 Factors Challenging the Market
          • 2.1.5.4.2.4 Analyst View
          • 2.1.5.4.2.5 Market Sizing and Forecast
        • 2.1.5.4.3 France
          • 2.1.5.4.3.1 Country Overview
          • 2.1.5.4.3.2 Driving Factors Market Growth
          • 2.1.5.4.3.3 Factors Challenging the Market
          • 2.1.5.4.3.4 Analyst View
          • 2.1.5.4.3.5 Market Sizing and Forecast
        • 2.1.5.4.4 Italy
          • 2.1.5.4.4.1 Country Overview
          • 2.1.5.4.4.2 Driving Factors Market Growth
          • 2.1.5.4.4.3 Factors Challenging the Market
          • 2.1.5.4.4.4 Analyst View
          • 2.1.5.4.4.5 Market Sizing and Forecast
        • 2.1.5.4.5 Spain
          • 2.1.5.4.5.1 Country Overview
          • 2.1.5.4.5.2 Driving Factors Market Growth
          • 2.1.5.4.5.3 Factors Challenging the Market
          • 2.1.5.4.5.4 Analyst View
          • 2.1.5.4.5.5 Market Sizing and Forecast
        • 2.1.5.4.6 Rest-of-Europe
          • 2.1.5.4.6.1 Regional Overview
          • 2.1.5.4.6.2 Driving Factors Market Growth
          • 2.1.5.4.6.3 Factors Challenging the Market
          • 2.1.5.4.6.4 Analyst View
          • 2.1.5.4.6.5 Market Sizing and Forecast

3 Competitive Benchmarking and Company Profiles

  • 3.1 Company Profiles
    • 3.1.1 Eurofins Scientific
      • 3.1.1.1 Overview
      • 3.1.1.2 Top Products/Product Portfolio
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Target Customers
      • 3.1.1.5 Key Personnel
      • 3.1.1.6 Analyst View
    • 3.1.2 Fios Genomics
      • 3.1.2.1 Overview
      • 3.1.2.2 Top Products/Product Portfolio
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Target Customers
      • 3.1.2.5 Key Personnel
      • 3.1.2.6 Analyst View
    • 3.1.3 QIAGEN
      • 3.1.3.1 Overview
      • 3.1.3.2 Top Products/Product Portfolio
      • 3.1.3.3 Top Competitors
      • 3.1.3.4 Target Customers
      • 3.1.3.5 Key Personnel
      • 3.1.3.6 Analyst View
    • 3.1.4 SOPHiA GENETICS
      • 3.1.4.1 Overview
      • 3.1.4.2 Top Products/Product Portfolio
      • 3.1.4.3 Top Competitors
      • 3.1.4.4 Target Customers
      • 3.1.4.5 Key Personnel
      • 3.1.4.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Bioinformatics Market (by Scenario), $Billion, 2024, 2025, and 2035
  • Figure 2: Europe Bioinformatics Market (by Product and Services), $Billion, 2024, 2029, and 2035
  • Figure 3: Europe Bioinformatics Market (by Sector), $Billion, 2024, 2029, and 2035
  • Figure 4: Europe Bioinformatics Market (by Application), $Billion, 2024, 2029, and 2035
  • Figure 5: Bioinformatics Market, $Billion, 2024 and 2035
  • Figure 6: Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 7: U.K. Bioinformatics Market, $Billion, 2023-2035
  • Figure 8: Germany Bioinformatics Market, $Billion, 2023-2035
  • Figure 9: France Bioinformatics Market, $Billion, 2023-2035
  • Figure 10: Italy Bioinformatics Market, $Billion, 2023-2035
  • Figure 11: Spain Bioinformatics Market, $Billion, 2023-2035
  • Figure 12: Rest-of-Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 13: Data Triangulation
  • Figure 14: Top-Down and Bottom-Up Approach
  • Figure 15: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Key Market Trends
  • Table 3: Bioinformatics Market, Regulatory Landscape
  • Table 4: Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
  • Table 5: Some of the Public and Private Funding in the Bioinformatics Industry
  • Table 6: Bioinformatics Market (by Region), $Billion, 2023-2035
  • Table 7: Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 8: Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 9: Europe Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 10: Europe Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 11: U.K. Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 12: U.K. Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 13: U.K. Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 14: Germany Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 15: Germany Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 16: Germany Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 17: France Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 18: France Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 19: France Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 20: Italy Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 21: Italy Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 22: Italy Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 23: Spain Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 24: Spain Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 25: Spain Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 26: Rest-of-Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 27: Rest-of-Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 28: Rest-of-Europe Bioinformatics Market (by Sector), $Billion, 2024-3-2035